跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 17 条关于
“spliceosome”
全部
17
临床试验
4
药物
1
机构
0
资讯
12
去年
Akari Therapeutics Secures India Patent for Novel Spliceosome-Inhibiting ADC Payload Technology
11个月前
Akari Therapeutics Secures $5 Million Financing to Advance Novel ADC Platform with Spliceosome Modulator Payload
去年
Akari Therapeutics Secures $7.6 Million Private Placement to Advance Novel ADC Platform
去年
Akari Therapeutics Appoints Mark F. Kubik to Lead Oncology Business Development for Novel ADC Platform
2个月前
The Splice of Life: How Alternative Splicing Is Reshaping the Therapeutic Landscape Across Rare Diseases and Oncology
去年
Emavusertib Shows Promise in FLT3-Mutated AML Patients Resistant to Prior Therapies
9个月前
Akari Therapeutics Reports Promising Preclinical Data for AKTX-101 in K-Ras Mutant Pancreatic Cancer
9个月前
Akari Therapeutics Initiates GMP Manufacturing for Novel ADC AKTX-101 with WuXi XDC Partnership
3个月前
Akari Reports Breakthrough Preclinical Data for AKTX-101 in KRAS-Mutated Pancreatic Cancer, Stock Surges 50%
5个月前
Rgenta Therapeutics to Present Phase 1 Clinical Data on RNA-Targeting Cancer Drug RGT-61159 at ASCO 2026
第 1 页,共 2 页
上一页
下一页